FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., updating the product's regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Dysmenorrhea
• Gout
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Naproxen sodium (naproxen sodium)

Snippet

SUPPL AP for NAPROXEN SODIUM (NAPROXEN SODIUM)